![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Assessing the Risks of Birth Defects Associated With Atazanavir Exposure in Pregnancy
|
|
|
Reported by Jules Levin
Tenth International Congress on Drug Therapy in HIV Infection, November 7-11, 2010, Glasgow, UK
Stephen Esker1, Jessica Albano2, Hugh Tilson3, Jonathan Uy1, Dilek Arikan4, Kathryn Krantz4, Maria Jesus Jimenez-Exposito5, Daniel Seekins1
1Bristol-Myers Squibb, Plainsboro, NJ, USA; 2Kendle International Inc, Durham, NC, USA; 3University of North Carolina, Gillings School of Global Public Health, Chapel Hill, NC, USA; 4Bristol-Myers Squibb, Hopewell, NJ, USA; 5Bristol-Myers Squibb, Paris, France
![](../images/122210/122210-1/con-1.gif)
![](../images/122210/122210-1/back-2.gif)
![](../images/122210/122210-1/reult-3.gif)
![](../images/122210/122210-1/birht-4.gif)
![](../images/122210/122210-1/atv-5.gif)
![](../images/122210/122210-1/class-6.gif)
![](../images/122210/122210-1/data-7.gif)
![](../images/122210/122210-1/ref-8.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|